Geven, A. Et Al. 2023. A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC-DAD-ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison. JOURNAL OF AOAC INTERNATIONAL , no.5 , 1145-1153.

Geven, A., ÖZCAN, S., LEVENT, S., & CAN, N. Ö., (2023). A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC-DAD-ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison. JOURNAL OF AOAC INTERNATIONAL , no.5, 1145-1153.

Geven, Aysun Et Al. "A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC-DAD-ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison," JOURNAL OF AOAC INTERNATIONAL , no.5, 1145-1153, 2023

Geven, Aysun Et Al. "A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC-DAD-ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison." JOURNAL OF AOAC INTERNATIONAL , no.5, pp.1145-1153, 2023

Geven, A. Et Al. (2023) . "A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC-DAD-ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison." JOURNAL OF AOAC INTERNATIONAL , no.5, pp.1145-1153.

@article{article, author={Aysun Geven Et Al. }, title={A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC-DAD-ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison}, journal={JOURNAL OF AOAC INTERNATIONAL}, year=2023, pages={1145-1153} }